221 related articles for article (PubMed ID: 33992835)
1. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
Cao JY; Zhou LT; Li ZL; Yang Y; Liu BC; Liu H
J Pharmacol Sci; 2020 Jul; 143(3):226-233. PubMed ID: 32446726
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.
Maayah ZH; Takahara S; Dyck JRB
Arch Toxicol; 2021 Jan; 95(1):1-9. PubMed ID: 32852568
[TBL] [Abstract][Full Text] [Related]
6. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
7. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice.
Wang T; Nowrangi D; Yu L; Lu T; Tang J; Han B; Ding Y; Fu F; Zhang JH
J Neuroinflammation; 2018 Jan; 15(1):2. PubMed ID: 29301581
[TBL] [Abstract][Full Text] [Related]
8. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 Receptor Agonist A-68930 Inhibits NLRP3 Inflammasome Activation, Controls Inflammation, and Alleviates Histopathology in a Rat Model of Spinal Cord Injury.
Jiang W; Huang Y; He F; Liu J; Li M; Sun T; Ren W; Hou J; Zhu L
Spine (Phila Pa 1976); 2016 Mar; 41(6):E330-4. PubMed ID: 26966979
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
[TBL] [Abstract][Full Text] [Related]
12. Honokiol antagonizes doxorubicin‑induced cardiomyocyte senescence by inhibiting TXNIP‑mediated NLRP3 inflammasome activation.
Huang PP; Fu J; Liu LH; Wu KF; Liu HX; Qi BM; Liu Y; Qi BL
Int J Mol Med; 2020 Jan; 45(1):186-194. PubMed ID: 31746354
[TBL] [Abstract][Full Text] [Related]
13. Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway.
Yang HB; Lu ZY; Yuan W; Li WD; Mao S
Biol Trace Elem Res; 2022 Jun; 200(6):2848-2856. PubMed ID: 34462843
[TBL] [Abstract][Full Text] [Related]
14. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.
Yan Y; Jiang W; Liu L; Wang X; Ding C; Tian Z; Zhou R
Cell; 2015 Jan; 160(1-2):62-73. PubMed ID: 25594175
[TBL] [Abstract][Full Text] [Related]
15. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
16. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.
Meng L; Lin H; Zhang J; Lin N; Sun Z; Gao F; Luo H; Ni T; Luo W; Chi J; Guo H
J Mol Cell Cardiol; 2019 Nov; 136():15-26. PubMed ID: 31445005
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
19. Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells.
Huang Z; Zhuang X; Xie C; Hu X; Dong X; Guo Y; Li S; Liao X
Cell Physiol Biochem; 2016; 40(6):1578-1590. PubMed ID: 27997926
[TBL] [Abstract][Full Text] [Related]
20. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
